Thomas Bengtsson

Title: Thomas Bengtsson: Inventor in Respiratory Medicine.

Introduction

Thomas Bengtsson is an inventor associated with Lund, Sweden, and Verona Pharma Plc. His patent work focuses on ensifentrine, a compound investigated for treating chronic obstructive pulmonary disease (COPD). The supplied information lists 2 patents.

Latest Patents

Bengtsson’s listed patents address potential uses of ensifentrine in people with COPD.

- **Ensifentrine (RPL554) for increasing trough lung function in COPD.** This invention concerns using ensifentrine, or a pharmaceutically acceptable salt, to increase trough lung function in patients with COPD. It also describes treatment for patients who may be susceptible to disturbed sleep.

- **Ensifentrine for decreasing the frequency or severity of COPD exacerbations.** This invention concerns using ensifentrine, or a pharmaceutically acceptable salt, to reduce the frequency or severity of COPD exacerbations. It also addresses treatment for patients susceptible to such exacerbations.

Career Highlights

The provided information associates Bengtsson’s patent activity with Verona Pharma Plc and highlights respiratory medicine as the focus of the listed inventions. The patent descriptions center on potential clinical benefits of ensifentrine for lung function and COPD exacerbations.

Collaborations

The supplied information names Tara Renae Rheault and Kathleen Rickard as Bengtsson’s coworkers. It does not specify their roles in the listed patents or describe particular collaborations.

Conclusion

Thomas Bengtsson’s listed inventions focus on ensifentrine-based approaches to COPD, including improving trough lung function and reducing exacerbations.